BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27796746)

  • 1. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
    de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
    Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphocytes response persists following Plasmodium berghei strain Anka infection resolution and may contribute to later experimental cerebral malaria outcomes.
    de Miranda AS; Ferreira RN; Vieira ÉLM; Abreu LKS; Brant F; Vieira LB; Ribeiro FM; Machado FS; Rachid MA; Teixeira AL
    J Neuroimmunol; 2019 May; 330():5-11. PubMed ID: 30763800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
    Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
    Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
    Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
    Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the neuropsychological mechanisms of 2,6-diisopropylphenol and N-methyl-D-aspartate receptor antagonist against electroconvulsive therapy-induced learning and memory impairment in depressed rats.
    Liu G; Liu C; Zhang XN
    Mol Med Rep; 2015 Sep; 12(3):3297-3308. PubMed ID: 25998151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the contribution of adult neurogenesis and hippocampal cell death in experimental cerebral malaria cognitive outcome.
    de Miranda AS; Brant F; Campos AC; Vieira LB; Rocha NP; Cisalpino D; Binda NS; Rodrigues DH; Ransohoff RM; Machado FS; Rachid MA; Teixeira AL
    Neuroscience; 2015 Jan; 284():920-933. PubMed ID: 25451296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
    Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
    PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets.
    Ichord RN; Johnston MV; Traystman RJ
    Brain Res Dev Brain Res; 2001 Jun; 128(2):139-48. PubMed ID: 11412899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
    PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
    Guo L; Salt TE; Maass A; Luong V; Moss SE; Fitzke FW; Cordeiro MF
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):626-33. PubMed ID: 16431960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction.
    Xu L; Qiu X; Wang S; Wang Q; Zhao XL
    Neurosci Bull; 2019 Apr; 35(2):347-361. PubMed ID: 30569431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.
    Dai M; Freeman B; Shikani HJ; Bruno FP; Collado JE; Macias R; Reznik SE; Davies P; Spray DC; Tanowitz HB; Weiss LM; Desruisseaux MS
    PLoS One; 2012; 7(10):e44117. PubMed ID: 23082110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
    de Sousa LP; de Almeida RF; Ribeiro-Gomes FL; de Moura Carvalho LJ; E Souza TM; de Souza DOG; Daniel-Ribeiro CT
    Parasit Vectors; 2018 Mar; 11(1):191. PubMed ID: 29554958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOC/oFQ and NMDA contribute to piglet hypoxic ischemic hypotensive cerebrovasodilation impairment.
    Armstead WM
    Pediatr Res; 2002 May; 51(5):586-91. PubMed ID: 11978881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc.
    Okada M; Fukuyama K; Kawano Y; Shiroyama T; Ueda Y
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00457. PubMed ID: 30784207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MK-801 or DNQX reduces electroconvulsive shock-induced impairment of learning-memory and hyperphosphorylation of Tau in rats].
    Liu C; Min S; Wei K; Liu D; Dong J; Luo J; Liu XB
    Sheng Li Xue Bao; 2012 Aug; 64(4):387-402. PubMed ID: 22907299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801.
    Brenner E; Kondziella D; Håberg A; Sonnewald U
    J Neurochem; 2005 Sep; 94(6):1594-603. PubMed ID: 16045441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.